Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Israel approves death penalty law for Palestinians convicted of attacks - 2Far-right leader Le Pen to attend Brigitte Bardot's funeral
- 3Share your pick for the riding area that characterizes your surf undertakings!
- 4Insight: Pills, TikTok, weight-loss apps and the consumer-driven future of GLP-1s
- 5Air Canada CEO To Resign After Backlash—Here’s Why Communication Skills Is Now A Leadership Requirement
- Key Training: Picking a Significant for Monetary Achievement
- Portugal among EU countries with the most people working close to 50 hours a week
- How to watch the 2025 Macy's Thanksgiving Day Parade for free
- The Most Compelling Books of the 10 years
- Consumer outlook on UK economy falls to two-year low
- Illustrations Gained from a Crosscountry Excursion
- Merz postpones Norway trip for Belgium talks on frozen Russian assets
- This Flashy Old-School Design Trend From Italy Still Has A Place In Modern Kitchens
- New dietary guidelines recommend more dairy, meat and fats: What to know
